Ac Immune Stock In The News

ACIU Stock  USD 2.52  0.22  8.03%   
The tone or emotional content of news articles related to AC Immune can affect its prices. Positive news sentiment can lead to an increase in demand for AC Immune's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of AC Immune's news coverage and content from conventional and social sources shows investors' bearish mood towards AC Immune. The specific impact of AC Immune news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of AC Immune's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using AC Immune headlines in addition to utilizing other, more conventional financial analysis modules. Check out AC Immune Backtesting and AC Immune Hype Analysis.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

AC Immune Today Top News and Investor Outlook

Yahoo News
Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround
https://finance.yahoo.com/news/down-35-7-4-weeks-143503312.html
 Bullish
Yahoo News
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
https://finance.yahoo.com/news/ac-immune-regain-global-rights-120000117.html
 Bullish
Yahoo News
AC Immune (ACIU) is a Great Momentum Stock: Should You Buy?
https://finance.yahoo.com/news/ac-immune-aciu-great-momentum-170005499.html
 Bullish
Yahoo News
5 Small-Cap Stocks to Play the January Effect
https://finance.yahoo.com/news/5-small-cap-stocks-play-145900292.html
 Bullish
Yahoo News
AC Immune (ACIU) Upgraded to Buy: Here's Why
https://finance.yahoo.com/news/ac-immune-aciu-upgraded-buy-170006780.html
 Bullish
Yahoo News
AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
https://finance.yahoo.com/news/ac-immune-progress-phase-2-131000855.html
 Bullish
Yahoo News
AC Immune Announces Pricing of Underwritten Offering of Common Shares
https://finance.yahoo.com/news/ac-immune-announces-pricing-underwritten-125600169.html
 Bullish
Yahoo News
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
https://finance.yahoo.com/news/ac-immune-targeted-anti-ptau-122200253.html
 Bullish
Yahoo News
AC Immune SA's (NASDAQ:ACIU) top owners are private equity firms with 37% stake, while 25% is held by individual investors
https://finance.yahoo.com/news/ac-immune-sas-nasdaq-aciu-104235870.html
 Bullish
Yahoo News
The Zacks Analyst Blog Highlights Biogen, Prothena, AC Immune's and Vaxxinity
https://finance.yahoo.com/news/zacks-analyst-blog-highlights-biogen-141000751.html
 Bullish

AC Immune Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide ACIU and other traded companies coverage. We help investors stay connected with ACIU headlines for the 15th of April 2024 to make an informed investment decision based on correlating the impacts of news items on ACIU Stock performance. Please note that trading solely based on the AC Immune hype is not for everyone as timely availability and quick action are needed to avoid losses.
AC Immune's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help AC Immune investors visualize upcoming and past events in order to time the market based on AC Immune noise-free hype analysis.
AC Immune stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the ACIU earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about AC Immune that are available to investors today. That information is available publicly through ACIU media outlets and privately through word of mouth or via ACIU internal channels. However, regardless of the origin, that massive amount of ACIU data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AC Immune news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AC Immune relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AC Immune's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AC Immune alpha.

ACIU Largest EPS Surprises

Earnings surprises can significantly impact AC Immune's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2017-11-13
2017-09-30-0.13-0.15-0.0215 
2017-08-09
2017-06-30-0.16-0.140.0212 
2016-11-11
2016-09-30-0.16-0.18-0.0212 
2020-05-04
2020-03-31-0.14-0.110.0321 
2018-08-08
2018-06-30-0.22-0.190.0313 
2018-11-13
2018-09-30-0.25-0.210.0416 
View All Earnings Estimates

AC Immune Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to AC Immune Stock. Current markets are slightly bearish. About 56% of major world exchanges and indexes are down. See today's market update for more information.
Yahoo News
11th of April 2024
We Think AC Immune Can Afford To Drive Business Growth
at finance.yahoo.com 
Google News at Macroaxis
1st of April 2024
AC Immune SA Short Interest Update - MarketBeat
at news.google.com 
Google News at Macroaxis
18th of March 2024
AC Immune SA Short Interest Down 6.0 percent in February - Defense World
at news.google.com 
sbwire news
15th of March 2024
ACIU Stock Earnings AC Immune Beats EPS, Beats Revenue for Q4 2023
at investorplace.com 
Investing News at Macroaxis
14th of March 2024
AC Immune earnings beat by CHF0.04, revenue fell short of estimates
at investing.com 
Google News at Macroaxis
8th of March 2024
AC Immune SA to Post Q1 2024 Earnings of Per Share, Leerink Partnrs Forecasts - Defense Wo...
at news.google.com 
Yahoo News
22nd of February 2024
AC Immune Announces Upcoming Presentations at ADPD 2024
at finance.yahoo.com 
Yahoo News
21st of February 2024
AbbVie Announces Appointment of New CEO Robert Michael
at finance.yahoo.com 
zacks News
30th of January 2024
Down -35.7 percent in 4 Weeks, Heres Why AC Immune Looks Ripe for a Turnaround
at zacks.com 
zacks News
18th of January 2024
AC Immune is a Great Momentum Stock Should You Buy
at zacks.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AC Immune in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AC Immune's short interest history, or implied volatility extrapolated from AC Immune options trading.
When determining whether AC Immune is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ACIU Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ac Immune Stock. Highlighted below are key reports to facilitate an investment decision about Ac Immune Stock:
Check out AC Immune Backtesting and AC Immune Hype Analysis.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for ACIU Stock analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Is AC Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.70)
Revenue Per Share
0.175
Quarterly Revenue Growth
14.8 K
Return On Assets
(0.18)
Return On Equity
(0.33)
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.